Home Healthcare Biotechnology Companion Diagnostics Market

Companion Diagnostics Market Size, Share & Trends Analysis Report By Technology (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Immunohistochemistry, In Situ Hybridization, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Central Nervous System Disorders, Virology Diseases, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 03, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Companion Diagnostics Market Size Analysis
    1. Introduction
    2. Companion Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR) 
      2. Next-generation Sequencing (NGS)
      3. Immunohistochemistry
      4. In Situ Hybridization
      5. Others
    3. Companion Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Autoimmune Diseases
      3. Cardiovascular Diseases
      4. Central Nervous System Disorders
      5. Virology Diseases
      6. Others
  7. North America Companion Diagnostics Market Size Analysis
    1. Introduction
    2. Companion Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR) 
      2. Next-generation Sequencing (NGS)
      3. Immunohistochemistry
      4. In Situ Hybridization
      5. Others
    3. Companion Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Autoimmune Diseases
      3. Cardiovascular Diseases
      4. Central Nervous System Disorders
      5. Virology Diseases
      6. Others
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
  8. Europe Companion Diagnostics Market Size Analysis
    1. Introduction
    2. Companion Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR) 
      2. Next-generation Sequencing (NGS)
      3. Immunohistochemistry
      4. In Situ Hybridization
      5. Others
    3. Companion Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Autoimmune Diseases
      3. Cardiovascular Diseases
      4. Central Nervous System Disorders
      5. Virology Diseases
      6. Others
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    6. France
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
  9. APAC Companion Diagnostics Market Size Analysis
    1. Introduction
    2. Companion Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR) 
      2. Next-generation Sequencing (NGS)
      3. Immunohistochemistry
      4. In Situ Hybridization
      5. Others
    3. Companion Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Autoimmune Diseases
      3. Cardiovascular Diseases
      4. Central Nervous System Disorders
      5. Virology Diseases
      6. Others
    4. China
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    7. India
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    9. Singapore
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
  10. Middle East and Africa Companion Diagnostics Market Size Analysis
    1. Introduction
    2. Companion Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR) 
      2. Next-generation Sequencing (NGS)
      3. Immunohistochemistry
      4. In Situ Hybridization
      5. Others
    3. Companion Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Autoimmune Diseases
      3. Cardiovascular Diseases
      4. Central Nervous System Disorders
      5. Virology Diseases
      6. Others
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
  11. LATAM Companion Diagnostics Market Size Analysis
    1. Introduction
    2. Companion Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR) 
      2. Next-generation Sequencing (NGS)
      3. Immunohistochemistry
      4. In Situ Hybridization
      5. Others
    3. Companion Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Autoimmune Diseases
      3. Cardiovascular Diseases
      4. Central Nervous System Disorders
      5. Virology Diseases
      6. Others
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR) 
        2. Next-generation Sequencing (NGS)
        3. Immunohistochemistry
        4. In Situ Hybridization
        5. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Cardiovascular Diseases
        4. Central Nervous System Disorders
        5. Virology Diseases
        6. Others
  12. Competitive Landscape
    1. Companion Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Abbott
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Agilent Technologies
    3. Hoffmann-La Roche Ltd
    4. Biomerieux SA
    5. Qiagen NV
    6. Almac Group
    7. Danaher Corporation
    8. Illumina, Inc.
    9. Myriad Genetics, Inc.
    10. Sysmex Corporation
    11. Thermo Fisher Scientific Inc.
    12. Abnova Corporation
    13. Guardant Health, Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Companion Diagnostics Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 3: Global Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 4: North America Companion Diagnostics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 5: North America Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 6: North America Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 7: U.S. Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 8: U.S. Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 9: Canada Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 10: Canada Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 11: Europe Companion Diagnostics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 12: Europe Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 13: Europe Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 14: U.K. Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 15: U.K. Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 16: Germany Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 17: Germany Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 18: France Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 19: France Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 20: Spain Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 21: Spain Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 22: Italy Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 23: Italy Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 24: Russia Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 25: Russia Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 26: Nordic Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 27: Nordic Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 28: Benelux Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 29: Benelux Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 30: Rest of Europe Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 31: Rest of Europe Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 32: APAC Companion Diagnostics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 33: APAC Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 34: APAC Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 35: China Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 36: China Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 37: Korea Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 38: Korea Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 39: Japan Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 40: Japan Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 41: India Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 42: India Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 43: Australia Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 44: Australia Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 45: Singapore Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 46: Singapore Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 47: Taiwan Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 48: Taiwan Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 49: South East Asia Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 50: South East Asia Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 51: Rest of Asia-Pacific Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 52: Rest of Asia-Pacific Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 53: Middle East and Africa Companion Diagnostics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 54: Middle East and Africa Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 55: Middle East and Africa Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 56: UAE Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 57: UAE Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 58: Turkey Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 59: Turkey Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 60: Saudi Arabia Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 61: Saudi Arabia Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 62: South Africa Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 63: South Africa Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 64: Egypt Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 65: Egypt Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 66: Nigeria Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 67: Nigeria Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 68: Rest of MEA Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 69: Rest of MEA Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 70: LATAM Companion Diagnostics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 71: LATAM Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 72: LATAM Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 73: Brazil Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 74: Brazil Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 75: Mexico Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 76: Mexico Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 77: Argentina Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 78: Argentina Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 79: Chile Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 80: Chile Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 81: Colombia Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 82: Colombia Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 83: Rest of LATAM Companion Diagnostics Market Size and Forecast By Technology - 2022-2034 (USD Billion)

Table 84: Rest of LATAM Companion Diagnostics Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.